Ligand Pharmaceuticals Inc. (LGND) Financials

Key financial figures for Ligand Pharmaceuticals Inc. (Q2 2026).

Revenue

$64M

Net Income

$49M

EPS

$2.42

Total Assets

$2.2B

Operating Cash Flow

$24M

Full income statement, balance sheet, and cash flow for Ligand Pharmaceuticals Inc. on SentiSense.